| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $33.17B | $31.80B | $29.77B | $27.52B | $25.37B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $27.11B | $26.47B | $24.74B | $23.68B | $21.11B |
| R&D | – | – | – | – | – |
| SG&A | $1.98B | $2.15B | $2.06B | $2.10B | $2.11B |
| Operating Income | $6.07B | $5.33B | $5.03B | $3.84B | $4.26B |
| Interest Expense | – | – | $347.00M | $304.00M | $232.00M |
| Tax Expense | $1.06B | $1.18B | $1.17B | $947.00M | -$70.00M |
| Net Income | $5.23B | $4.15B | $4.25B | $2.42B | $4.17B |
| EPS (basic) | 5.4600 | 4.0300 | 3.8500 | 2.1000 | 3.5500 |
| EPS (diluted) | 5.4100 | 3.9900 | 3.8400 | 2.0900 | 3.5200 |
| Shares (diluted) | $968.00M | $1.04B | $1.11B | $1.16B | $1.19B |